Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dr. Ruth Pat-Horenzcyk, Herzog Hospital
ClinicalTrials.gov Identifier:
NCT00463138
First received: April 19, 2007
Last updated: September 3, 2013
Last verified: September 2013
  Purpose

Researchers examined perceived satisfaction and perceived increase or decrease in symptoms among recipients of treatment at the Jerusalem Center for the Treatment of Psychotrauma, using self report methods. Researchers hypothesized that a significant number of recipients would report a decrease in their symptoms and general satisfaction with the treatment they received.


Condition Intervention Phase
Healthy
Behavioral: Crisis intervention
Phase 0

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma

Resource links provided by NLM:


Further study details as provided by Herzog Hospital:

Primary Outcome Measures:
  • depressive symptoms, anxiety, PDS, which measures subjective response to trauma, symptoms, and and level of functioning. [ Time Frame: April 2007- March 2008 ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • level of family, friend, and other support, Self-Efficacy Scale [ Time Frame: Aprol 2007- March2008 ] [ Designated as safety issue: Yes ]

Other Outcome Measures:
  • Traumatic Events Screening Inventory (TESI) [ Time Frame: April 2008- March 2008 ] [ Designated as safety issue: Yes ]

Enrollment: 100
Study Start Date: April 2007
Study Completion Date: March 2008
Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
Detailed Description:

Researchers conducted a follow-up study of clients of Meytiv, the clinical branch of the Jerusalem Center for the Treatment of Psychotrauma. Researchers plan to use the results of the study to better understand the demographics of those who come to the Center, and to improve the services offered to our clients. Before beginning treatment, every Meytiv client filled out a questionnaire in which information is requested regarding demographics, trauma history, symptoms, and various levels of functioning. Researchers administered a similar self-report questionnaire to all clients upon completion of treatment. The follow-up questionnaire contained the following several indices: the Traumatic Events Screening Inventory (TESI), which requests a client's trauma history; the Multidimensional Scale of Perceived Social Support, which measures level of family, friend, and other support; the Brief Symptom Inventory, which measures level of various psychiatric symptoms, including somatic complaints, depressive symptoms, anxiety, and paranoid or hostile thoughts; the Self-Efficacy Scale, which measures level of self-reliance and confidence in one's ability to cope with stressors; and PDS, which measures subjective response to trauma, symptoms, and and level of functioning. This questionnaire, which mirrors one completed by all Meytiv's clients before treatment, was administered to those clients who completed treatment within a year of the study. Clients completed the follow-up questionnaire on condition that if they were in need of further treatment, Meytiv would refer them to the appropriate provider. Responses will be coded and analyzed to check significance among potentially related variables, including demographic variables. Most importantly, results of the follow-up questionnaire will be compared to its parallel from the beginning of treatment in order to examine what effects our treatment has on one's symptoms, and whether our clients have been satisfied

  Eligibility

Ages Eligible for Study:   12 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year

Criteria

Inclusion Criteria:

  • All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year

Exclusion Criteria:

  • Clients under the age of 12
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00463138

Sponsors and Collaborators
Herzog Hospital
Investigators
Principal Investigator: Danny Brom, Ph.D Israel Center for the Treatment of Psychotrauma
  More Information

No publications provided

Responsible Party: Dr. Ruth Pat-Horenzcyk, Research director, Herzog Hospital
ClinicalTrials.gov Identifier: NCT00463138     History of Changes
Other Study ID Numbers: Brom3CTIL
Study First Received: April 19, 2007
Last Updated: September 3, 2013
Health Authority: Israel: Ministry of Health

Keywords provided by Herzog Hospital:
perceived increase or decrease in symptoms post treatment
Satisfaction with the treatment

ClinicalTrials.gov processed this record on August 01, 2014